Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease

被引:173
作者
McBride, P
Schrott, HG
Plane, MB
Underbakke, G
Brown, RL
机构
[1] Univ Wisconsin, Sch Med, HEART Prevent Cardiol Program, Madison, WI USA
[2] Univ Iowa, Sch Med, Dept Prevent Med, Iowa City, IA USA
关键词
D O I
10.1001/archinte.158.11.1238
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Clinical trials demonstrate significant benefit from cholesterol management for patients with cardiovascular disease (CVD). National guidelines recommending goals for screening and treatment were published in 1993 and widely disseminated. This study examines cholesterol screening and management by primary care physicians after the guidelines were released. Methods: Medical records and patient surveys provided data for 603 patients with CVD, aged 27 to 70 years, from 45 practices in 4 states during 1993 to 1995. Physician surveys measured estimated performance and other variables. Physician and patient factors associated with adherence, or lack of adherence, to national guidelines were examined using univariate and multivariate analyses. Results: A total of 199 patients (33%) with CVD were not screened with lipid panels, 271 patients (45%) were not receiving dietary counseling, and 404 (67%) were not receiving cholesterol medication. Only 84 patients (14%) with CVD had achieved the recommended low-density lipoprotein level of less than 2.58 mmol/L (100 mg/dL) and 302 (50%) had triglyceride levels lower than 2.26 mmol/L (200 mg/dL). Patients with a revascularization history and higher low-density lipoprotein and/or triglyceride levels were more likely to receive treatment, but other patient factors, including CVD risk factors, did not predict treatment. Physician specialty was not associated with differences in treatment, but physicians in practice for fewer years ordered more lipid panels. Conclusions: Most patients with CVD in primary care were not receiving cholesterol screening and management as recommended by the National Cholesterol Education Program guidelines in the 2 years after their release. Increasing cholesterol screening and treatment should be a priority for practice quality improvement and could result in significant reductions in CVD events for high-risk patients.
引用
收藏
页码:1238 / 1244
页数:7
相关论文
共 20 条
[1]  
*AD TREATM PAN 2, 1993, JAMA-J AM MED ASSOC, V369, P3015
[2]  
Campeau L, 1997, NEW ENGL J MED, V336, P153
[3]   LOW RATE OF TREATMENT OF HYPERCHOLESTEROLEMIA BY CARDIOLOGISTS IN PATIENTS WITH SUSPECTED AND PROVEN CORONARY-ARTERY DISEASE [J].
COHEN, MV ;
BYRNE, MJ ;
LEVINE, B ;
GUTOWSKI, T ;
ADELSON, R .
CIRCULATION, 1991, 83 (04) :1294-1304
[4]  
DAVIS JE, 1992, J FAM PRACTICE, V35, P385
[5]  
DIXON WJ, 1990, BMDP STAT SOFTW MAN
[6]  
Eaton C B, 1994, Fam Med, V26, P587
[7]   CHOLESTEROL REDUCTION IN CARDIOVASCULAR-DISEASE - CLINICAL BENEFITS AND POSSIBLE MECHANISMS [J].
LEVINE, GN ;
KEANEY, JF ;
VITA, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (08) :512-521
[8]  
MCBRIDE P, IN PRESS WIS MED J
[9]  
McBride PE, 1996, J FAM PRACTICE, V43, P389
[10]   Smoking screening and management in primary care practices [J].
McBride, PE ;
Plane, MB ;
Underbakke, G ;
Brown, RL ;
Solberg, LI .
ARCHIVES OF FAMILY MEDICINE, 1997, 6 (02) :165-172